Abstract
Purpose
Preparation, in vitro and in vivo evaluation of indomethacin-loaded polymeric micelles based on amphiphilic polyphosphazene.
Methods
Amphiphilic polyphosphazenes (PNIPAAm/EAB-PPPs) with poly (N-isopropylacrylamide) (PNIPAAm) and ethyl 4-aminobenzoate (EAB) as side groups were synthesized through thermal ring-opening polymerization and subsequent substitution reactions. Indomethacin (IND) loaded polymeric micelles based on PNIPAAm/EAB-PPPs were prepared by dialysis procedure. In vitro IND release kinetics was investigated in 0.1 M PBS (pH 7.4), while in vivo pharmacokinetics was performed in Sprague–Dawley rats. In vivo pharmacodynamic study was carried out based on two animal models, i.e. carrageenan-induced acute paw edema and complete Freund’s adjuvant (CFA) induced ankle arthritis model.
Results
Drug loading capacity of micelles based on this type of amphiphilic copolymers was mainly determined by copolymer composition and the chemical structure of drug. In addition to the compatibility between drug and micellar core, hydrogen bonding interaction between drug and hydrophilic corona may significantly influence drug loading as well. In vitro drug release in PBS suggested that there was no significant difference in release rate between micelles based on copolymers with various EAB content. Compared with the rats administered with free IND aqueous solution, IND concentration in rats’ plasma showed a prolonged maintenance in experimental group treated with IND-loaded polymeric micelles. In vivo pharmacodynamic study indicated that sustained therapeutic efficacy could be achieved through topical injection of the aqueous solution of IND-loaded micelles. Local delivery of IND can avoid the severe gastrointestinal stimulation, which was frequently associated with oral administration as evidenced by ulceration evaluation.
Conclusions
The promising results of current preliminary study suggest that this type of amphiphilic copolymers could be used as injectable drug carriers for hydrophobic drugs.
Similar content being viewed by others
Abbreviations
- AET·HCl:
-
2-aminoethanethiol hydrochloride
- AUC:
-
area under the concentration–time curve
- AIBN:
-
2, 2′-azobisisobutyronitrile
- AUMC:
-
area under the first moment of the plasma concentration–time curve
- CFA:
-
complete Freund’s adjuvant
- CMC:
-
critical micelle concentration
- DMS:
-
dexamethasone
- DMAc:
-
dimethylacetamide
- DMF:
-
N,N-dimethylformamide
- DMSO:
-
dimethyl sulphoxide
- DSC:
-
differential scanning calorimeter
- EAB:
-
ethyl 4-aminobenzoate
- GPC:
-
gel permeation chromatography
- HPLC:
-
high-performance liquid chromatography
- IBU:
-
ibuprofen
- IND:
-
indomethacin
- KET:
-
ketoprofen
- LCST:
-
lower critical solution temperature
- MRT:
-
mean residence time
- MPG:
-
medroxyprogesterone acetate
- NAP:
-
naproxen
- PBS:
-
phosphate buffered solution
- PNIPAAm:
-
poly (N-isopropylacrylamide)
- PNIPAAm/EAB-PPP:
-
amphiphilic polyphosphazene with PNIPAAm and EAB as side groups
- PNS:
-
predinisone acetate
- RA:
-
rheumatoid arthritis
- SD:
-
standard deviation
- THF:
-
tetrahydrofuran
References
E. D. J. Harris. Rheumatoid arthritis: pathophysiology and implications for therapy. New Engl. J. Med. 322:1277–1289 (1990).
T. Doanand, and E. Massarotti. Rheumatoid arthritis: an overview of new and emerging therapies. J. Clin. Pharmacol. 45:751–762 (2005).
J. Steinmeyerand, and Y. T. Konttinen. Oral treatment options for degenerative joint disease-presence and future. Adv. Drug Delv. Rev. 58:168–211 (2006).
N. Gerwin, C. Hops, and A. Lucke. Intraarticular drug delivery in osteoarthritis. Adv. Drug Delv. Rev. 58:226–242 (2006).
S. Abramson. Drug delivery in degenerative joint disease: where we are and where to go?. Adv. Drug Delv. Rev. 58:125–127 (2006).
C. T. Wang, J. Lin, and C. J. Chang. Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. A meta-analysis of randomized controlled trials. J. Bone Jt. Surg. 86:538–544 (2004).
X. Ayral. Injections in the treatment of osteoarthritis. Best Pract. Res. Clin Rheumatol. 15:609–626 (2001).
K. E. Brown, K. Leong, C. H. Huang, R. Dalal, G. D. Green, H. B. Haimes, P. A. Jimenez, and J. Bathon. Gelatin/chondroitin 6-sulfate microspheres for the delivery of therapeutic proteins to the joint. Arthritis Rheum. 41:2185–2195 (1998).
M. Trif, C. Guillen, D. M. Vaughan, J. M. Telfer, J. M. Brewer, A. Roseanu, and J. H. Brock. Liposomes as possible carriers for lactoferrin in the local treatment of inflammatory diseases. Exp. Biol. Med. 226:559–564 (2001).
E. Horisawa, T. Hirota, S. Kawazoe, J. Yamada, H. Yamamoto, H. Takeuchi, and Y. Kawashima. Prolonged anti-inflammatory action of dl-lactide/glycolide copolymer nanospheres containing betamethasone sodium phosphate for an intra-articular delivery system in antigen-induced arthritic rabbit. Pharm. Res. 19:403–410 (2002).
C. Allen, D. Maysinger, and A. Eisenberg. Nano-engineering block copolymer aggregates for drug delivery. Colloids Surf. B 16:3–27 (1999).
M. C. Jonesand, and J. C. Leroux. Polymeric micelles-a new generation of colloidal drug carriers. Eur. J. Pharm. Biopharm. 48:101–111 (1999).
K. Kataoka, A. Harada, and Y. Nagasaki. Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv. Drug Delv. Rev. 47:113–131 (2001).
Y. Kakizawaand, and K. Kataoka. Block copolymer micelles for delivery of gene and related compounds. Adv. Drug Delv. Rev. 54:203–222 (2002).
R. Duncan. The dawning era of polymer therapeutics. Nat. Rev. Drug Discov. 2:347–360 (2003).
D. Wang, S. C. Miller, M. Sima, D. Parker, H. Buswell, K. C. Goodrich, P. Kopeckova, and J. Kopecek. The arthrotropism of macromolecules in adjuvant-induced arthritis rat model: A preliminary study. Pharm. Res. 21:1741–1749 (2004).
D. Wang, S. C. Miller, X. M. Liu, B. Anderson, X. S. Wang, and S. R. Goldring. Novel dexamethasone-HPMA copolymer conjugate and its potential application in treatment of rheumatoid arthritis. Arthritis Res. Ther. 9:R2 (2007).
Y. K. Chang, E. S. Powell, and H. R. Allcock. Environmentally responsive micelles from polystyrene-poly[bis(potassium carboxylatophenoxy)phosphazenel block copolymers. J. Polym. Sci. Pol. Chem. 43:2912–2920 (2005).
R. Song, Y. J. Jun, J. I. Kim, C. Jin, and Y. S. Sohn. Synthesis, characterization, and tumor selectivity of a polyphosphazene-platinum(II) conjugate. J. Control. Release 105:142–150 (2005).
J. X. Zhang, L. Y. Qiu, K. J. Zhu, and Y. Jin. Thermosensitive micelles self-assembled by novel N-Isopropylacrylamide oligomer grafted polyphosphazene. Macromol. Rapid Commun. 25:1563–1567 (2004).
J. X. Zhang, L. Y. Qiu, Y. Jin, and K. J. Zhu. Physicochemical characterization of polymeric micelles constructed from novel amphiphilic polyphosphazene with poly(N-isopropylacrylamide) and ethyl 4-aminobenzoate as side groups. Colloids Surf. B 43:123–130 (2005).
J. X. Zhang, L. Y. Qiu, and K. J. Zhu. Solvent controlled multi-morphological self-assembly of amphiphilic graft copolymers. Macromol. Rapid Commun. 26:1716–1723 (2005).
J. X. Zhang, L. Y. Qiu, Y. Jin, and K. J. Zhu. Multimorphological self-assemblies of amphiphilic graft polyphosphazenes with oligopoly (N-isopropylacrylamide) and ethyl 4-aminobenzoate as side groups. Macromolecules 39:451–455 (2006).
G. Chen, and A. S. Hoffman. Graft copolymers that exhibit temperature-induced phase transitions over a wide range of pH. Nature 373:49–52 (1995).
Y. S. Sohn, Y. H. Cho, H. Baek, and O. S. Jung. Synthesis and properties of low molecular weight polyphosphazenes. Macromolecules 28:7566–7568 (1995).
J. Sato, T. Amizuka, Y. Niida, M. Umetsu, and K. Ito. Simple, rapid and sensitive method for the determination of indomethacin in plasma by high-performance liquid chromatography with ultraviolet detection. J. Chromatogr. B 692:241–244 (1997).
I. G. Otternessand, and M. L. Bliven. Laboratory models for testing non-steroidal anti-inflammatory drugs. Wiley, New York, 1985.
R. Nagarajan, M. Barry, and E. Ruckenstein. Unusual selectivity in solubilization by block copolymer micelles. Langmuir 2:210–215 (1986).
J. B. Liu, Y. H. Xiao, and C. Allen. Polymer-drug compatibility: a guide to the development of delivery systems for the anticancer agent, ellipticine. J. Pharm. Sci. 93:132–143 (2004).
A. Benahmed, M. Ranger, and J. C. Leroux. Novel polymeric micelles based on the amphiphilic diblock copolymer poly(N-vinyl-2-pyrrolidone)-blockpoly(D,L-lactide). Pharm. Res. 18:323–328 (2001).
S. E. Andersson, K. Lexmuller, A. Johansson, and G. M. Ekstrom. Tissue and intracellular pH in normal periarticular soft tissue and during different phases of antigen induced arthritis in the rat. J. Rheumatol. 26:2018–2024 (1999).
V. A. Bobkov, T. N. Brylenkova, and R. S. Moiseenko. Acid-base balance of the synovial fluid in patients with RA debute. Terapevt. Arkh. 72:35–38 (2000).
J. R. Levick. Hypoxia and acidosis in chronic inflammatory arthritis:Relation to vascular supply and dynamic effusion pressure. J. Rheumatol. 17:579–582 (1990).
S. B. La, T. Okano, and K. Kataoka. Preparation and characterization of the micelle-forming polymeric drug indomethacin-incorporated poly (ethylene oxide)-poly (β-benzyl L-aspartate) block copolymer micelles. J. Pharm. Sci. 85:85–90 (1996).
Acknowledgement
Financial support from National Natural Science Foundation of China (No. 30371768) and Zhejiang Natural Science Foundation (No. R204233) is gratefully acknowledged.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Zhang, J.X., Yan, M.Q., Li, X.H. et al. Local Delivery of Indomethacin to Arthritis-Bearing Rats through Polymeric Micelles Based on Amphiphilic Polyphosphazenes. Pharm Res 24, 1944–1953 (2007). https://doi.org/10.1007/s11095-007-9322-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-007-9322-4